Comprehensive gene expression profiling has identified four major molecular subtypes of breast cancer, namely, luminal A breast cancer, luminal B breast cancer, HER2-positive breast cancer, and triple-negative breast cancer (TNBC), with TNBC accounting for 15–20% of all BCs. This evidence concerns the gene ERBB2 and breast carcinoma.